Advertisement

Topics

China Sky One Medical, Inc. Company Profile

23:57 EDT 20th March 2019 | BioPortfolio

China Sky One Medical, Inc., a Nevada corporation, is a holding company. The Company engages in the manufacturing, marketing and distribution of pharmaceutical, medicinal and diagnostic products. Through its wholly-owned subsidiaries, Harbin Tian Di Ren Medical Science and Technology Company ("TDR"), Harbin First Bio-Engineering Company Limited ("First"), Heilongjiang Tianlong Pharmaceutical, Inc. ("Tianlong") and Peng Lai Jin Chuang Pharmaceutical Company ("Jin Chuang") the Company manufactures and distributes over-the-counter pharmaceutical products, which make up its major revenue source. For more information, visit http://www.cski.com.cn .


News Articles [1431 Associated News Articles listed on BioPortfolio]

As Trump's Trade War Grows, China Hits Medical Device Makers

China’s latest retaliatory tariffs have hit $4.7 billion in U.S. medical technology exports, the Advanced Medical Technology Association (AdvaMed) said.

Yunhu Completes A+ Round for Internet-based China Primary Medical Care

Yunhu Technology, a Hangzhou company that offers an internet platform for China primary medical services, has secured "tens of millions RMB" in a Series A+ financing. Founded in 2017, Yunhu claims to ...

China OKs Chi-Med's metastatic colorectal cancer therapy

China's National Medical Products Administration granted approval to Hutchison China MediTech's Elunate, or fruquintinib.  -More- 

China Medical In-Licenses China Rights to VAXIMM's Immunotherapies

China Medical System in-licensed China/Asian rights (excluding Japan) to a portfolio of oral cancer immunotherapy candidates developed by VAXIMM, a Swiss/German biotech. In return for the rights, CMS ...

Hutchison China MediTech (HCM) - Fruquintinib capsules approved in China

Edison Investment Research - Pharmaceutical & healthcare - Hutchison China MediTech: Hutchison China MediTech’s (HCM) lead TKI asset, fruquintinib, has received China registration approval from ...

Download Presentation : Healthcare in China – A Golden Investment Opportunity

What are the biggest drivers of China’s Total Healthcare Expenditure? Why is China’s healthcare industry robust and growing? How can one negotiate China’s healthcare reforms and chart their succ...

Fountain Medical Development: Clinical trials, government involvement and China's future

In this interview, filmed at BioPharm in San Francisco, Dr Fintan Walton speaks with Joanne Jiang, Executive Vice President at Fountain Medical Development, a new contract research organisation in Chi...

Chi-Med’s fruquintinib gets approval for colorectal cancer in China

Hutchison China MediTech (Chi-Med) has secured approval from the National Medical Products Administration of China (NMPA) for the use of...Read More... The post Chi-Med’s fruquintinib gets approval ...

PubMed Articles [3062 Associated PubMed Articles listed on BioPortfolio]

GIS-based method to delimit spheres of influence for a medical consortium: Experience of a pediatric medical consortium, Shanghai.

To improve the utilization efficiency of health care services, the concept of a "regional medical consortium" has attracted more attention during the most recent round of health care reform in China. ...

Selective admission policy of medical undergraduates in western China: applicants' real attitudes to the choice of a rural medical career.

Since 2010, the Chinese government has been introducing selective admission policy to recruit rural students for 5-year western medicine and traditional Chinese medicine undergraduate education in ord...

Psychological strains, depressive symptoms, and suicidal ideation among medical and non-medical staff in urban china.

The Strain Theory of Suicide has been tested and well supported regarding rural people who show risk of suicide. Studies on the impact of psychological strains on psychopathologies and suicidality in ...

Preparing the next generation of health professionals to tackle climate change: Are China's medical students ready?

Climate change is the biggest global health threat of the 21st century. Medical students will lead the health sector responses and adaptation efforts in the near future, yet little is known in China a...

Medical education reform in China.

Clinical Trials [2818 Associated Clinical Trials listed on BioPortfolio]

Realize the Current Situation of COPD Patients in China

This is a multi-centre, prospective, observational study to realize the current situation of COPD patients in China. About 5000 COPD patients will be enrolled from 50 participating sites a...

Multicenter Registry of Pediatric Lupus Nephritis in China

This study is designed to evaluate the efficacy and safety of the current treatment option and outcome of pediatric lupus nephritis patients in China. Investigators will perform prospectiv...

Hospital-level Variation in the Management of Blood Pressure and Low-density Lipoprotein in the Outpatient Hypertensives in China-a Cross Sectional Study

To investigate the proportion, medication use and control rate of metabolic abnormalities such as dyslipidemia in outpatients with hypertension in different levels of hospitals in China. T...

Standard Medical Management in Secondary Prevention of Ischemic Stroke in China

The purposes of the study are to analyse the cross-section data of secondary stroke prevention in China and to carry out a standard medical management including medicine and interactive ed...

National-wide Survey on Primary Health Care in China

The survey aims to support health policy making, this survey aims to comprehensively assess the capability and quality of PHC in different regions in China. The study is based on the China...

Companies [1759 Associated Companies listed on BioPortfolio]

China Medical Technologies

The China Medical Technologies Inc. is a high-tech enterprise specialized in R&D and manufacturing medical equipment and bio-medical products. The company was established in 1999, and was awarded ISO ...

China Yongxin Pharmaceuticals, Inc.

Founded in 1993, China Yongxin Pharmaceutical, Inc. is a vertically-integrated retailer and distributor of Chinese traditional medicines, pharmaceutical preparations, natural health products, heal...

China Yongxin Pharmaceutical, Inc.

Founded in 1993, China Yongxin Pharmaceutical is a manufacturer, retailer and distributor of Chinese traditional medicines, pharmaceutical preparations, natural health products, health food, cosme...

China SHESAYS Medical Cosmetology Inc.

China SHESAYS, founded in 2005, operates a chain of specialized medical cosmetology hospitals, clinics and skincare centers in Sichuan province. The Company has a full range of services including ...

China Aoxing Pharmaceutical Company, Inc.

China Aoxing Pharmaceutical Company, Inc. (OTCBB: CAXG) is a pharmaceutical company located in China specializing in research, development, manufacturing and distribution of a variety of narcotics...

More Information about "China Sky One Medical, Inc." on BioPortfolio

We have published hundreds of China Sky One Medical, Inc. news stories on BioPortfolio along with dozens of China Sky One Medical, Inc. Clinical Trials and PubMed Articles about China Sky One Medical, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of China Sky One Medical, Inc. Companies in our database. You can also find out about relevant China Sky One Medical, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Corporate Database Quicklinks



Searches Linking to this Company Record